Amarin Corp Plc (AMRN)

[Biobillionair]

Study,
Agree, it not if, it's when. It very well might be after Anchor, which of course extended our exclusivity long term with the exclusivity starting Dec 20 at Anchor PDUFA. New MAPPs are still popping up so timing is impossible.

Also new documents have been posted on Marine approval, many redacted pages r/t NCE.

I was also excited to see Brilinta ($130/script) sales come in at $15 Million with script number similar to Vascepa's($190/script). Yes, an apple to oranges comparison, but still cool. $15 million happens to be TOP sales estimate for Vascepa Q1:)

Shorts have dug a seriously big hole.